Cystic Fibrosis Foundation-Al Birmingham, AL - 35242

Cystic Fibrosis Foundation-Al is categorized under Medical Research in Birmingham, AL .

Cystic Fibrosis Foundation-Al was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 8134101 by the NAICS.

If you are seeking more information, feel free to contact Jennifer Mc Euen, Executive Director at the company’s single location by writing to 200 Cahaba Park Circle # 114, Birmingham, Alabama AL 35242 or by phoning (205) 870-8565. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cystic Fibrosis Foundation-Al
Contact Person: Jennifer Mc Euen, Executive Director
Address: 200 Cahaba Park Circle # 114, Birmingham, Alabama 35242
Phone Number: (205) 870-8565
Website Address: cff.org
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 8134101
Share This Business:

Cystic Fibrosis Foundation-Al was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 8134101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Jennifer Mc Euen, Executive Director for inquiries that concern Cystic Fibrosis Foundation-Al by calling the company number (205) 870-8565, as your correspondence is most welcome. Additionally, the physical location of the single location of Cystic Fibrosis Foundation-Al can be found at the coordinates 33.43004,-86.70793 as well as the street address 200 Cahaba Park Circle # 114 in Birmingham, Alabama 35242.

For its online presence, you may visit Cystic Fibrosis Foundation-Al’s website at cff.org and engage with its social media outlets through on Twitter and on Facebook.